期刊文献+

尿酸结石患者尿液中的微晶组分及其与结石形成的关系 被引量:2

Components of Urinary Crystallites in Urine of Uric Acid Stone Formers and Its Relationship with Formation of Stones
下载PDF
导出
摘要 采用X射线衍射(XRD)、傅里叶变换红外(FTIR)光谱、纳米粒度仪、扫描电子显微镜(SEM)和透射电子显微镜(TEM)研究了10例尿酸结石患者尿微晶的组分、Zeta电位、形貌及其与尿酸结石形成的关系。结果表明,尿酸结石患者的尿pH值较低,大都在4.8~5.7之间;尿微晶的主要成分为尿酸,其粒度分布很不均匀,从几纳米到几十微米不等,并有聚集现象。相比健康对照者尿纳米微晶的Zeta电位(-10.1mV),尿酸结石患者的Zeta电位负值更小(-6.02 mV)。对这些患者进行药物治疗(服用柠檬酸钾)后,尿pH可上升到6.5左右,此时尿液中的大部分尿酸转变为溶解度显著增加的尿酸盐,因此,尿酸结石形成的危险性显著降低。本文结果表明,尿石组分、尿微晶组分及尿pH三者之间存在密切的联系。 The components,zeta potential,morphology of nanocrystallites in urines of 10 uric acid stone formers as well as their relationship with the formation of uric acid stones were comparatively studied using X-ray diffraction(XRD),Fourier transform infrared(FT-IR) spectroscopy,nanoparticle size analyzer,scanning electron microscopy(SEM) and transmission electron microscopy(TEM).The urine pH of uric acid stone formers was relatively low within the range of 4.8 to 5.7.The main constituent of urinary crystallites was uric acid.Their particle size distribution was highly uneven,ranging from several nanometers to several tens of micrometers,and obvious aggregation was observed.The zeta potential of urinary crystallites in ten lithogenic patients was-6.02 mV,which was higher than that in ten normal subjects(-10.1 mV).After drug therapies (potassium citrate was taken),the urine pH value of the uric acid stone formers increased to 6.5 or so,and at this pH value most of the uric acid had changed to urate.Since the solubility of urate increased greatly than uric acid,the risk of the formation of uric acid stone reduced.The results in this paper showed that there was a close relationship among stone components,urinary crystallites composition and urine pH.
出处 《光谱学与光谱分析》 SCIE EI CAS CSCD 北大核心 2010年第9期2350-2354,共5页 Spectroscopy and Spectral Analysis
基金 广东省科技攻关项目(2009B030801236) 国家自然科学基金项目(30672103)资助
关键词 纳米微晶 ZETA电位 FTIR XRD 纳米粒度仪 尿酸结石 Nanocrystallite Zeta potential FTIR XRD Nanoparticle size analyzer Uric acid stone
  • 相关文献

参考文献16

  • 1Shekarriz B, Stoller M L. J. Urol. , 2002, 168:1307.
  • 2Ouyang J M. Spectros. Lett. , 2004, 37(6): 633.
  • 3邝荔,谭燕华,欧阳健明,钟红兴,梁蔚波,林雪莹,邱月琼.广东省东江流域泌尿系结石化学成份分析[J].广东医学,2002,23(10):1029-1031. 被引量:18
  • 4Daudon M, Hennequin C, Boujelben G, et al. Kidney Int. , 2005, 67:1934.
  • 5黄志杰,李君君,何节玉,欧阳健明.草酸钙结石患者尿液中纳米级和微米级晶体研究[J].光谱学与光谱分析,2010,30(7):1913-1917. 被引量:3
  • 6King M, McClure W F, Andrews L C, et al. 1992 Powder Diffraction File Alphabetical Index, Inorganic Phases/Organic Phases. International Center for Diffraction Data: 1601 Park Lane, Pennsylvania, U. S. A. , 1992. 19081.
  • 7Maurice-Estepa L, Levillain P, Lacour B, et al. Clin. Chim. Acta, 2000, 298: 1.
  • 8Benramdane L, Bouatia M, Idrissi M O B, et al. Spectros. Lett. , 2008, 41(2): 72.
  • 9孟茵,戴克胜,李玉云,李德发,郝艳梅,许惠云,沈继龙.皖北地区泌尿系统结石化学成份分析[J].上海医学检验杂志,2000,15(2):85-86. 被引量:6
  • 10Grases F, Sanchis P, Perello J, et al. Int. J. Urol. , 2006, 13:252.

二级参考文献30

  • 1陈寅虹,施纪文,顾可粱.363份尿结石定性结果分析[J].临床检验杂志,1993,11(2):98-99. 被引量:3
  • 2邓耀良,覃光熙.草酸钙结石患者尿液中柠檬酸/草酸比值[J].中华实验外科杂志,1994,11(4):205-206. 被引量:7
  • 3Rez S S P.Urol.Res.,2007,35:287.
  • 4Tsujihata M Int.J.Urol.,2008,15:115.
  • 5Robertson W G,Peacock M,Nordin B E C.Lancet,1969,2:21.
  • 6Hallson P C,Rose G A.Brit.J.Urol.,1978,50:442.
  • 7Robert M,Boularan A M,Delbos O,et al.Urol.Int.,1998,60:41.
  • 8Robert M,Boularan A M,Delbos O,et al.Eur.Urol.,1996,29(4):456.
  • 9King M,McClure W F,Andrews L C.Powder Diffraction File Alphabetic Index,Inorganic Phases/Organic Phases,International Center for Diffraction Data:Newtown Square,PA,1992.
  • 10Moawad M M J.Coord Chem,2002,50(1):61.

共引文献23

同被引文献18

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部